Charles River Laboratories International's 15min chart triggers MACD and KDJ Death Crosses.
ByAinvest
Monday, Oct 6, 2025 2:35 pm ET1min read
CRL--
The MACD (Moving Average Convergence Divergence) Death Cross occurs when the MACD line crosses below the signal line, indicating a potential bearish trend. Similarly, the KDJ (Keltner Channels) Death Cross suggests a breakdown in the stock's momentum, further supporting the notion of a downward trend.
These technical indicators come on the heels of recent market movements. On the same day, Charles River Laboratories' stock jumped 2.6% after Barclays upgraded the company to Overweight from Equal Weight and raised its price target to $195 [1]. However, the stock cooled down to $179.33, up 2.3% from the previous close, indicating a more cautious market sentiment.
The market's volatility has been evident, with Charles River Laboratories experiencing 17 moves greater than 5% over the last year. Despite the recent upgrade and positive momentum, the stock remains 18.7% below its 52-week high of $220.69 [1]. Investors who bought $1,000 worth of shares five years ago would now be looking at an investment worth $763.20.
As of September 12, 2025, the stock has been down 1.8% since the beginning of the year. The technical indicators suggest that the stock's momentum is shifting towards the downside, which may lead to further decreases in its value. Investors should closely monitor the stock's performance and consider the implications of these technical signals.
According to the 15-minute chart of Charles River Laboratories International, there have been notable technical indicators triggered. Specifically, a MACD Death Cross and a KDJ Death Cross occurred on October 6, 2025 at 14:30. These indicators suggest that the stock price has the potential to continue declining. Furthermore, the momentum of the stock price is shifting towards the downside, which may lead to further decreases in its value.
Charles River Laboratories International (NYSE:CRL) has been experiencing notable technical indicators that suggest potential downward pressure on its stock price. On October 6, 2025, at 14:30, the 15-minute chart of Charles River Laboratories International triggered a MACD Death Cross and a KDJ Death Cross. These technical indicators are often interpreted as signals of a potential trend reversal, suggesting that the stock price may continue to decline.The MACD (Moving Average Convergence Divergence) Death Cross occurs when the MACD line crosses below the signal line, indicating a potential bearish trend. Similarly, the KDJ (Keltner Channels) Death Cross suggests a breakdown in the stock's momentum, further supporting the notion of a downward trend.
These technical indicators come on the heels of recent market movements. On the same day, Charles River Laboratories' stock jumped 2.6% after Barclays upgraded the company to Overweight from Equal Weight and raised its price target to $195 [1]. However, the stock cooled down to $179.33, up 2.3% from the previous close, indicating a more cautious market sentiment.
The market's volatility has been evident, with Charles River Laboratories experiencing 17 moves greater than 5% over the last year. Despite the recent upgrade and positive momentum, the stock remains 18.7% below its 52-week high of $220.69 [1]. Investors who bought $1,000 worth of shares five years ago would now be looking at an investment worth $763.20.
As of September 12, 2025, the stock has been down 1.8% since the beginning of the year. The technical indicators suggest that the stock's momentum is shifting towards the downside, which may lead to further decreases in its value. Investors should closely monitor the stock's performance and consider the implications of these technical signals.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet